Cover Image
市場調查報告書

神經調節設備市場 2018年∼2028年:腦深部刺激療法,脊髓,迷走神經,薦骨神經及胃電刺激用途的收益預測

Global Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

出版商 Visiongain Ltd 商品編碼 585547
出版日期 內容資訊 英文 221 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經調節設備市場 2018年∼2028年:腦深部刺激療法,脊髓,迷走神經,薦骨神經及胃電刺激用途的收益預測 Global Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications
出版日期: 2018年04月09日 內容資訊: 英文 221 Pages
簡介

本報告提供全球神經調節設備的市場調查,市場定義和概要,產品、技術的分類各種用途,各刺激處的趨勢與市場規模的變化與預測,各地區、主要國家的詳細分析,主要企業簡介等彙整。

第1章 報告概要

第2章 簡介:神經調節

  • 神經調節
  • 神經調節的各種技術
    • 電刺激
    • 藥物療法
  • 神經調節的各種用途
    • 疼痛
    • 憂鬱
    • 航班、尿失禁
    • 聽覺障礙
    • 心血管疾病:心律不整、心絞痛
    • 神經退化性疾病:帕金森氏症

第3章 全球市場分析、預測

  • 市場成果
  • 市場預測
  • 產業趨勢

第4章 脊髓刺激部門分析、預測

  • 市場概要
  • 市場預測
  • 暢銷產品、開發中的產品
  • 各種用途
  • 市場趨勢、預測

第5章 腦深部刺激部門分析、預測

  • 市場概要
  • 市場預測
  • 暢銷產品、開發中的產品
  • 各種用途
  • 市場趨勢、預測

第6章 胃電刺激部門分析、預測

  • 市場概要
  • 市場預測
  • 暢銷產品、開發中的產品
  • 各種用途
  • 市場趨勢、預測

第7章 迷走神經刺激部門分析、預測

  • 市場概要
  • 市場預測
  • 暢銷產品、開發中的產品
  • 各種用途
  • 市場趨勢、預測

第8章 薦椎神經刺激部門分析、預測

  • 市場概要
  • 市場預測
  • 暢銷產品、開發中的產品
  • 各種用途
  • 市場趨勢、預測

第9章 其他神經調節技術部門分析、預測

  • 技術概要
    • 三叉神經刺激
    • 人工電子耳
    • 經顱磁刺激 (TMS)
    • 經顱直流刺激(tDCS)
    • 超音波神經調節
  • 市場預測

第10章 北美市場預測

  • 概要
  • 美國
  • 加拿大

第11章 南美市場預測

  • 概要
  • 巴西
  • 墨西哥
  • 其他

第12章 歐洲市場預測

  • 概要
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他

第13章 亞太地區市場預測

  • 概要
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 韓國
  • 其他

第14章 其他地區市場預測

  • 概要
  • 中東
  • 非洲

第15章 主要製造商

  • Medtronic
  • Boston Scientific
  • St. Jude Medical(SJM)
  • Cyberonics
  • 其他

第16章 定性分析

  • SWOT分析
  • STEP分析
  • 致力於臨床試驗的企業

第17章 總論

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0299

The neuromodulation devices market is estimated to grow at a CAGR of 11.7% in the first half of the forecast period. The Spinal Cord Stimulation (SCS) submarket is estimated to account for 43.6% share of this market in 2018.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 221-page report you will receive 125 charts- all unavailable elsewhere.

The 221-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Neuromodulation Devices market forecasts from 2018-2028

This report also breaks down the revenue forecast for the global neuromodulation devices market by type:

  • Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
  • Sacral Nerve Stimulation (SNS)
  • Gastric Electrical Stimulation (GES)
  • Other Applications

This report discusses the market trends and lists the leading products/pipeline products of each submarket.

This report provides individual revenue forecasts to 2028 for these regional and national markets:

  • North America: the US and Canada
  • Europe: France, Germany, Italy, U.K, Spain, Russia, Rest of Europe
  • Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific
  • Latin America: Brazil, Mexico, Rest of Latin America
  • Rest of the World: Middle East, Africa

Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.

Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry:

  • Medtronic
  • Boston Scientific
  • St Jude Medical (Abbott)
  • Cyberonics (LivaNova)
  • Stryker Corporation
  • Nevro Corp.
  • SetPoint Medical
  • Functional Neuromodulation
  • Neurotherapies Reset
  • Wringless Implantable Stretchable Electronics (WISE)
  • SceneRay
  • Mindray

Visiongain's study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.

Buy our report today ‘Global Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications ’.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Overview of the World Market for Neuromodulation Devices
  • 1.2. Why You Should Read This Report
  • 1.3. How this Report Delivers
  • 1.4. Main Questions Answered by this Analysis
  • 1.5. Who is this Report For?
  • 1.6. Methodology
  • 1.7. Frequently Asked Questions (FAQ)
  • 1.8. Associated Visiongain Reports
  • 1.9. About Visiongain

2. Introduction to Neuromodulation

  • 2.1. Neuromodulation
  • 2.2. Techniques Used in Neuromodulation
    • 2.2.1. Electrical Stimulation Techniques
    • 2.2.2. Pharmacological Therapy
  • 2.3. Application of Neuromodulation
    • 2.3.1. Pain
    • 2.3.2. Depression
    • 2.3.3. Epilepsy
    • 2.3.4. Faecal and Urinary Incontinence
    • 2.3.5. Hearing Disorders - Profound Deafness
    • 2.3.6. Cardiovascular Diseases - Arrhythmia and Angina

3. Global Neuromodulation Devices Market 2018-2028

  • 3.1. Neuromodulation Devices Market: 2018
  • 3.2. Neuromodulation Devices Market Forecast by Type: 2018-2028
  • 3.3. Neuromodulation Devices Market Forecast by Region: 2018-2028
  • 3.4. Neuromodulation Devices: Industry Trends, 2018-2028
    • 3.4.1. Industry Trends - Ageing Population
    • 3.4.2. Rising Prevalence of Chronic Diseases
    • 3.4.3. Industry Trends - Personalised Healthcare
    • 3.4.4. Industry Trends - National Regulations
    • 3.4.5. Political Uncertainty and Security Risk across the World
    • 3.4.6. Industry Trends - Economic Challenges
    • 3.4.7. Industry Trends - Mergers and Acquisitions

4. Spinal Cord Stimulation Submarket, 2018-2028

  • 4.1. Spinal Cord Stimulation (SCS) Market Overview, 2018
  • 4.2. SCS Market Forecast: 2018-2028
  • 4.3. Top Selling & Pipeline SCS Devices, 2018
  • 4.4. Applications of Spinal Cord Stimulation
  • 4.5. SCS Market Trends: 2018-2028

5. Deep Brain Stimulation Submarket, 2018-2028

  • 5.1. Deep Brain Stimulation (DBS) Market Overview, 2018
  • 5.2. DBS Market Forecast: 2018-2028
  • 5.3. Top Selling & Pipeline DBS Devices, 2018
  • 5.4. Applications of Deep Brain Stimulation
  • 5.5. DBS Market Trends: 2018-2028

6. Gastric Electrical Stimulation Submarket, 2018-2028

  • 6.1. Gastric Electrical Stimulation (GES) Market Overview, 2018
  • 6.2. GES Market Forecast: 2018-2028
  • 6.3. Top Selling GES Devices, 2018
  • 6.4. Applications of Gastric Electrical Stimulation
  • 6.5. GES Market Trends: 2018-2028

7. Vagus Nerve Stimulation Submarket, 2018-2028

  • 7.1. Vagus Nerve Stimulation (VNS) Market Overview, 2018
  • 7.2. VNS Market Forecast: 2018-2028
  • 7.3. Top Selling & Pipeline VNS Devices, 2018
  • 7.4. Applications of Vagus Nerve Stimulation
  • 7.5. VNS Market Trends: 2018-2028

8. Sacral Nerve Stimulation Submarket, 2018-2028

  • 8.1. Sacral Nerve Stimulation (SNS) Market Overview, 2018
  • 8.2. SNS Market Forecast: 2018-2028
  • 8.3. Top Selling & Pipeline SNS Devices, 2018
  • 8.4. Applications of Sacral Nerve Stimulation
  • 8.5. SNS Market Trends: 2018-2028

9. Other Neuromodulation Technologies Submarket, 2018-2028

  • 9.1. Other Neuromodulation Technologies Overview, 2018
    • 9.1.1. Trigeminal Nerve Stimulation
    • 9.1.2. Cochlear Implants
    • 9.1.3. Transcranial Magnetic Stimulation (TMS)
    • 9.1.4. Transcranial Direct Current Stimulation (tDCS)
    • 9.1.5. Ultrasonic Neuromodulation
  • 9.2. Other Neuromodulation Techniques Forecast: 2018-2028

10. North American Neuromodulation Devices Market 2018-2028

  • 10.1. Overview: North American Neuromodulation Devices Market 2018
  • 10.2. The US Neuromodulation Devices Market: 2018-2028
    • 10.2.1. The US Neuromodulation Devices Market Forecast: 2018-2028
  • 10.3. The Canadian Neuromodulation Devices Market: 2018-2028
    • 10.3.1. The Canadian Neuromodulation Devices Market Forecast: 2018-2028

11. Latin American Neuromodulation Devices Market 2018-2028

  • 11.1. Overview: Latin American Neuromodulation Devices Market 2018
  • 11.2. The Brazilian Neuromodulation Devices Market: 2018-2028
    • 11.2.1. The Brazilian Neuromodulation Devices Market: Economic and Political Challenges Affecting Prospects
    • 11.2.2. The Brazilian Neuromodulation Devices Market Forecast: 2018-2028
  • 11.3. The Mexican Neuromodulation Devices Market: 2018-2028
    • 11.3.1. The Mexican Neuromodulation Devices Market Forecast: 2018-2028
  • 11.4. The rest of Latin America Neuromodulation Devices Market: 2018-2028
    • 11.4.1. The rest of Latin America Neuromodulation Devices Market Forecast: 2018-2028

12. European Neuromodulation Devices Market 2018-2028

  • 12.1. Overview: European Neuromodulation Devices Market 2018
  • 12.2. The German Neuromodulation Devices Market: 2018-2028
    • 12.2.1. The German Neuromodulation Devices Market Forecast: 2018-2028
  • 12.3. The French Neuromodulation Devices Market: 2018-2028
    • 12.3.1. The French Neuromodulation Devices Market - the Economy and its Implications
    • 12.3.2. The French Neuromodulation Devices Market Forecast: 2018-2028
  • 12.4. The UK Neuromodulation Devices Market: 2018-2028
    • 12.4.1. The UK Neuromodulation Devices Market Forecast - Political Challenges
    • 12.4.2. The UK Neuromodulation Devices Market Forecast: 2018-2028
  • 12.5. The Italian Neuromodulation Devices Market: 2018-2028
    • 12.5.1. The Italian Neuromodulation Devices Market Outlook
    • 12.5.2. The Italian Neuromodulation Devices Market Forecast: 2018-2028
  • 12.6. The Spanish Neuromodulation Devices Market: 2018-2028
    • 12.6.1. The Spanish Neuromodulation Devices Market Forecast: 2018-2028
  • 12.7. The Russian Neuromodulation Devices Market: 2018-2028
    • 12.7.1. The Russian Neuromodulation Devices Market Forecast: 2018-2028
  • 12.8. The rest of European Neuromodulation Devices Market: 2018-2028
    • 12.8.1. The rest of European Neuromodulation Devices Market Forecast: 2018-2028

13. Asia-Pacific Neuromodulation Devices Market 2018-2028

  • 13.1. Overview: Asia-Pacific Neuromodulation Devices Market 2018
  • 13.2. The Japanese Neuromodulation Devices Market: 2018-2028
    • 13.2.1. The Japanese Neuromodulation Devices Market -Regulation Effects
    • 13.2.2. The Japanese Neuromodulation Devices Market Forecast: 2018-2028
  • 13.3. The Chinese Neuromodulation Devices Market: 2018-2028
    • 13.3.1. The Chinese Neuromodulation Devices Market - Amendments to Regulations
    • 13.3.2. The Chinese Neuromodulation Devices Market Forecast: 2018-2028
  • 13.4. The Indian Neuromodulation Devices Market: 2018-2028
    • 13.4.1. The Indian Neuromodulation Devices Market Forecast: 2018-2028
  • 13.5. The Australian Neuromodulation Devices Market: 2018-2028
    • 13.5.1. The Australian Neuromodulation Devices Market Forecast: 2018-2028
  • 13.6. The South-Korean Neuromodulation Devices Market: 2018-2028
    • 13.6.1. The South-Korean Neuromodulation Devices Market Forecast: 2018-2028
  • 13.7. The rest of Asia-Pacific Neuromodulation Devices Market: 2018-2028
    • 13.7.1. The rest of Asia-Pacific Neuromodulation Devices Market Forecast: 2018-2028

14. Rest of the world Neuromodulation Devices Market 2018-2028

  • 14.1. Overview: Rest of the world Neuromodulation Devices Market 2018
  • 14.2. The Middle-Eastern Neuromodulation Devices Market: 2018-2028
    • 14.2.1. The Middle-Eastern Neuromodulation Devices Market Forecast: 2018-2028
  • 14.3. The African Neuromodulation Devices Market: 2018-2028
    • 14.3.1. The African Neuromodulation Devices Market Forecast: 2018-2028

15. Neuromodulation Devices Market: Manufacturers

  • 15.1. Medtronic
    • 15.1.1. Sales and Recent Performance Analysis, 2017
    • 15.1.2. Medtronic International Operations
    • 15.1.3. Medtronic News
    • 15.1.4. Medtronic Market Outlook
  • 15.2. Boston Scientific Corporation
    • 15.2.1. Sales and Recent Performance Analysis: 2017
    • 15.2.2. Boston Scientific International Operations
    • 15.2.3. Boston Scientific-Neuromodulation Performance
    • 15.2.4. Boston Scientific News
    • 15.2.5. Boston Scientific Market Outlook
  • 15.3. St. Jude Medical (SJM) (now an Abbott company)
    • 15.3.1. Sales and Recent Performance Analysis: 2016
    • 15.3.2. Abbott International Operations, 2017
    • 15.3.3. Abbot/ SJM News
    • 15.3.4. SJM - Market Outlook
  • 15.4. Cyberonics (now a LivaNova Company)
    • 15.4.1. Sales and Recent Performance Analysis: 2017
    • 15.4.2. LivaNova Company International Operations
    • 15.4.3. Cyberonics News
    • 15.4.4. Cyberonics (LivaNova) Market Outlook
  • 15.5. Other Companies
    • 15.5.1. Stryker Corporation
    • 15.5.2. Nevro Corp.
  • 15.5.2.1. Nevro Corp News.
    • 15.5.3. SetPoint Medical
    • 15.5.4. Functional Neuromodulation
    • 15.5.5. Neurotherapies Reset
    • 15.5.6. Wiringless Implantable Stretchable Electronics (WISE)
    • 15.5.7. SceneRay
    • 15.5.8. Mindray

16. Qualitative Analysis of the Neuromodulation Devices Market, 2017

  • 16.1. SWOT Analysis of the Neuromodulation Devices Market
    • 16.1.1. Strengths of the Market
    • 16.1.2. Weaknesses
    • 16.1.3. Opportunities in the Neuromodulation Devices Market
    • 16.1.4. Threats Facing the Neuromodulation Devices Market
  • 16.2. STEP Analysis of the Neuromodulation Devices Market
    • 16.2.1. Social Factors: The Role of Neuroethics
    • 16.2.2. Technological Developments: Drive towards Non-Invasive Methods
    • 16.2.3. Economic Restraints: High Production Costs
    • 16.2.4. Economic Potential: Emerging Markets Create Demand
    • 16.2.5. Political Issues: Strong Government Influence
  • 16.3. Snapshot of Companies in Active Clinical Trials
    • 16.3.1. Neuromodulation Pipeline Products -2016-2018

17. Conclusions

  • 17.1. The United States Retains its Position as Market Leader
  • 17.2. Growing Incidences of Neurological Diseases
  • 17.3. Ageing Population Drives Growth
  • 17.4. China and India will lead the Emerging Markets
  • 17.5. The Future of the Market - Deep Brain Stimulation and Vagus Nerve Stimulation
  • 17.6. Concluding Remarks
    • Appendices
    • Associated Visiongain Reports
    • Visiongain Report Sales Order Form
    • Appendix A
    • About Visiongain
    • Appendix B
    • Visiongain Report Evaluation Form

List of Tables

  • Table 3.1: Global Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 3.2: Global Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 4.1: SCS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 4.2: Leading & Pipeline SCS Devices, 2018
  • Table 5.1: DBS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 5.2: Leading & Pipeline DBS Devices, 2018
  • Table 6.1: GES Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 6.2: Leading GES Devices, 2018
  • Table 7.1: VNS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 7.2: Leading VNS & Pipeline Devices, 2018
  • Table 8.1: SNS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 8.2: Leading & Pipeline SNS Devices, 2018
  • Table 9.1: Leading & Pipeline Other Neuromodulation Devices, 2018
  • Table 9.2: Other Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 10.1: North American Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 10.2: North American Neuromodulation Devices Market by type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 10.3: The US Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 10.4: The Canadian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 11.1: Latin American Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 11.2: Latin American Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 11.3: The Brazilian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 11.4: The Mexican Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 11.5: The rest of Latin America Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.1: European Neuromodulation Devices Market by Country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.2: European Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.3: The German Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.4: The French Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.5: The UK Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.6: The Italian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.7: The Spanish Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.8: The Russian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 12.9: The rest of European Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 13.1: Asia-Pacific Neuromodulation Devices Market, by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 13.2: Asia-Pacific Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 13.3: The Japanese Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 13.4: The Chinese Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 13.5: The Indian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 13.6: The Australian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 13.7: The South-Korean Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 13.8: The rest of Asia-Pacific Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 14.1: Rest of the world Neuromodulation Devices Market by Country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 14.2: Rest of the world Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 14.3: The Middle-Eastern Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 14.4: The African Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028
  • Table 16.1: Companies in Active Clinical Trials 2018-2028

List of Figures

  • Figure 1.1: Neuromodulation Devices Market Segmentation, 2018
  • Figure 3.1: Global Neuromodulation Devices Market by Type: Market Share (%) 2018
  • Figure 3.2: Global Neuromodulation Devices Market by Type: Market Share (%) 2028
  • Figure.3.3: Global Neuromodulation Devices Market by Country: Market Share (%) 2018
  • Figure 3.4: Global Neuromodulation Devices Market by Country: Market Share (%) 2028
  • Figure 3.5: Global Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 3.6: Global Neuromodulation Devices Market: Drivers and Restraints
  • Figure 4.1: SCS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 5.1: DBS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 6.1: GES Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 7.1: VNS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 8.1: SNS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 9.1: Other Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 10.1: North American Neuromodulation Devices Market by Country: Market Share (%) 2018
  • Figure 10.2: North American Neuromodulation Devices Market by Country: Market Share (%)2028
  • Figure 10.3: North American Neuromodulation Devices Market by Type: Market Share (%) 2018
  • Figure 10.4: North American Neuromodulation Devices Market by Type: Market Share (%)2028
  • Figure 10.5: North American Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 10.6: The US Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 10.7: The Canadian Neuromodulation Devices Market Revenue Forecast ($m) AGR (%), 2018-2028
  • Figure 11.1: Latin American Neuromodulation Devices Market by Country: Market Share (%) 2018
  • Figure 11.2: Latin American Neuromodulation Devices Market by Country: Market Share (%) 2028
  • Figure 11.3: Latin American Neuromodulation Devices Market by Type: Market Share (%) 2018
  • Figure 11.4: Latin American Neuromodulation Devices Market by Type: Market Share (%) 2028
  • Figure 11.5: Latin American Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 11.6: The Brazilian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 11.7: The Mexican Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 11.8: The rest of Latin America Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 12.1: European Neuromodulation Devices Market by Country: Market Share (%) 2018
  • Figure 12.2: European Neuromodulation Devices Market by Country: Market Share (%) 2028
  • Figure 12.3: European Neuromodulation Devices Market by Type: Market Share (%) 2018
  • Figure 12.4: European Neuromodulation Devices Market by Type: Market Share (%) 2028
  • Figure 12.5: European Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 12.6: The German Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 12.7: The French Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 12.8: The UK Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 12.9: The Italian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 12.10: The Spanish Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 12.11: The Russian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 12.12: The rest of European Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 13.1: Asia-Pacific Neuromodulation Devices Market by Country: Market Share (%) 2018
  • Figure 13.2: Asia-Pacific Neuromodulation Devices Market by Country: Market Share (%) 2028
  • Figure 13.3: Asia-Pacific Neuromodulation Devices Market by Type: Market Share (%) 2018
  • Figure 13.4: Asia-Pacific Neuromodulation Devices Market by Type: Market Share (%) 2028
  • Figure 13.5: Asia-Pacific Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 13.6: The Japanese Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure13.7: The Chinese Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 13.8: The Indian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 13.9: The Australian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 13.10: The South-Korean Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 13.11: The rest of Asia-Pacific Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 14.1: Rest of the world Neuromodulation Devices Market by Country: Market Share (%) 2018
  • Figure 14.2: Rest of the world Neuromodulation Devices Market by Country: Market Share (%) 2028
  • Figure 14.3: Rest of the world Neuromodulation Devices Market by Type: Market Share (%) 2018
  • Figure 14.4: Rest of the world Neuromodulation Devices Market, by type: Market Share (%)2028
  • Figure 14.5: Rest of the world Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 14.6: The Middle-Eastern Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 14.7: The African Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028
  • Figure 15.1: Neuromodulation Devices Market: Market Share Analysis, 2016
  • Figure 15.2: Medtronic Revenue ($m), 2013-2017
  • Figure 15.3: Medtronic Operating Sectors (%), 2017
  • Figure 15.4: Medtronic Sales Shares (%), 2017
  • Figure 15.5: Boston Scientific Revenues ($m), 2013-2017
  • Figure 15.6: Boston Scientific Operating Sectors (%), 2017
  • Figure 15.7: Boston Scientific Sector Shares (%), 2017
  • Figure 15.8: Boston Scientific World Sales Shares (%), 2017
  • Figure 15.9: Boston Scientific Geographical Sales Shares (%), 2017
  • Figure 15.10: Boston Scientific Neuromodulation Historical Revenue ($m), 2015-2017
  • Figure 15.11: Boston Scientific Neuromodulation Revenue Shares (%) within Med-Surgical Sector, 2016
  • Figure 15.12: Abbott/ St. Jude Neuromodulation Revenues ($m), 2016
  • Figure 15.13: Abbott Operating Sectors (%) (2017)
  • Figure 15.14: Cardiovascular and Neuromodulation Operating Sectors (%), 2017
  • Figure 15.15: Abbott World Sales Shares (%), 2017
  • Figure 15.16: LivaNova Company Revenues ($m), 2015-2017
  • Figure 15.17: LivaNova Company Operating Sectors (%) (2017)
  • Figure 15.18: LivaNova World Sales for Neuromodulation Devices Shares (%), 2017
  • Figure 15.19: Nevro Corp. Revenue ($m), 2017
  • Figure 15.20: Nevro Corp World Sales for Neuromodulation Devices Shares (%), 2017
  • Figure 16.1: SWOT Analysis of the Neuromodulation Devices Market, 2017
  • Figure 16.2: STEP Analysis of the Neuromodulation Devices Market, 2017

Companies Listed

  • Abbott
  • Accellent
  • Advanced Uro-Solutions
  • Aleva Neurotherapeutics
  • Atrotech
  • Autonomic Technologies
  • Avery Biomedical
  • Axonics Modulation
  • Bard Electrophysiology
  • Bayer AG
  • BioControl Medical
  • Bioness, Inc.
  • BlueWind
  • Boston Scientific
  • CardioMEMS
  • Cerbomed GmbH
  • CerebralRx
  • CerebroMed
  • Cogentix Medical
  • Covidien
  • CVRx, Inc
  • Cyberonics
  • DBI
  • Deep Brain Innovations
  • electroCore
  • EndoNovo
  • EndoStim Inc
  • Enopace Biomedical
  • EnteroMedics
  • Functional Neuromodulation
  • Genesys Capital
  • Greatbatch
  • Halo Neuroscience
  • ImThera Medical
  • ImThera Medical, Inc.
  • InCube Labs
  • Integer Holdings Corporation
  • IoGyn, Inc.
  • Laborie Medical Technologies
  • Lake Region Medical
  • LivaNova
  • MagStim
  • MainStay Medical
  • Medtronic
  • Medtronic Eindhoven Design Centre (MEDC)
  • Medtronic International Trading Sarl
  • MedtronicNeuro
  • MetaCure
  • Metavention
  • Microtransponder
  • Mindray
  • Nanostim
  • NDI Medical
  • NeuImpulse
  • NeuroPace
  • NeuroSigma
  • NeuroStar
  • Neurotherapies Reset
  • NeuroTherm
  • NeuroVista Corp
  • NeuSpera
  • Nevro
  • Newronika
  • Nexstim plc
  • nUro Inc
  • Nuvectra Corporation
  • QiG Group,LLC
  • Rio Grande
  • Sapiens SBS
  • Sapiens Steering Brain Stimulation
  • SceneRay
  • Scion NeuroStim
  • SetPoint Medical
  • Sorin
  • SorinSpA
  • Soterix Medical
  • Spinal Modulation Inc
  • SPR Therapeutics
  • St. Jude Medical
  • StarMedTec
  • StimGuard, LLC.
  • Stimwave
  • Stryker Corporation
  • Synapse Medical
  • Urolplasty

List of Organisations Mentioned in the Report:

  • Australia Institute of Health and Welfare
  • CFDA (the China Food and Drug Administration)
  • FDA
  • Foundation Medical Partners
  • Gaceta Médica de México
  • Health Canada
  • National Institute for Health and Care Excellence (NICE)
  • Nordic Neuromodulation Society
  • North American Neuromodulation Society (NANS)
  • Organization for Economic Cooperation and Development (OECD)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • The University of Texas Health Science Center
  • University of Miami
  • World Health Organization (WHO)
Back to Top